Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 25, 2018
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
[ Thu, Jan 25th 2018
] - WOPRAI
Wed, January 24, 2018
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
[ Wed, Jan 24th 2018
] - WOPRAI
Sumant Kulkarni Maintained (BIIB) at Hold with Increased Target to $350 on, Jan 24th, 2018
Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Hold with Increased Target from $340 to $350 on, Jan 24th, 2018.
Sumant has made no other calls on BIIB in the last 4 months.
There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 2 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Carter Gould of "UBS" Maintained at Hold with Increased Target to $318 on, Wednesday, October 25th, 2017
- Robyn Karnauskas of "Citigroup" Downgraded from Strong Buy to Hold on, Monday, October 23rd, 2017
These are the ratings of the 9 analyists that currently disagree with Sumant
- Jay Olson of "Oppenheimer" Initiated at Buy and Held Target at $350 on, Thursday, November 9th, 2017
- Ian Somaiya of "BMO Capital" Maintained at Buy with Increased Target to $386 on, Monday, November 6th, 2017
- Jeffrey Silber of "BMO Capital" Upgraded from Hold to Buy on, Wednesday, October 25th, 2017
- Adnan Butt of "Guggenheim" Initiated at Strong Buy and Held Target at $402 on, Tuesday, October 24th, 2017
- Christopher Raymond of "Piper Sandler" Initiated at Buy and Held Target at $390 on, Monday, October 23rd, 2017
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $365 on, Wednesday, October 18th, 2017
- Salim Syed of "Mizuho" Upgraded from Hold to Strong Buy on, Tuesday, October 17th, 2017
- Thomas Shrader of "Stifel" Upgraded from Hold to Strong Buy on, Tuesday, October 17th, 2017
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy on, Thursday, October 5th, 2017
